University of Liverpool PhD student reports from the 8th World Congress on Targeting Phage Therapy (2025)

Ruby Darwin, a PhD student in the University of Liverpool's Department of Infection Biology and Microbiomes, attended the two-day Targeting Phage Therapy 2025 conference virtually with IVES small grant funds. She highlights a first clinical trial of phages in Japan for Pseudomonas aeruginosa otitis externa, DUOFAG clinical trials of a phage spray for skin infections and wounds, freeze-dried phage tablets, phages against quorum sensing genes and phage–bacteria co-evolution.